Search

Start Over Keyword Autosomal dominant polycystic kidney disease

  • Effect of Statin Therapy on the Progression of Autosomal Dominant Polycystic Kidney Disease. A Secondary Analysis of the HALT PKD Trials.

    Effect of Statin Therapy on the Progression of Autosomal Dominant Polycystic Kidney Disease. A Secondary Analysis of the HALT PKD Trials.
    Authors:Godela M. Brosnahan, University of ColoradoKaleab Z. Abebe, University of PittsburghFrederic Rahbari Oskoui, Emory UniversityCharity G. Patterson, Carolinas HealthCare SystemKyongtae T. Bae, University of PittsburghRobert W. Schrier, University of ColoradoWilliam E. Braun, Cleveland ClinicArlene B Chapman, Emory UniversityMichael F. Flessner, National Institutes of HealthPeter C. Harris, Mayo ClinicRonald D. Perrone, Tufts Medical CenterTheodore I. Steinman, Beth Israel Deaconess Medical CenterVicente E. Torres, Mayo Clinic
    Date:2017
    Publisher:Bentham Science Publishers
    Publication Version:Author Accepted Manuscript (After Peer Review)

  • Rationale and Design of a Clinical Trial Investigating Tolvaptan Safety and Efficacy in Autosomal Dominant Polycystic Kidney Disease

    Rationale and Design of a Clinical Trial Investigating Tolvaptan Safety and Efficacy in Autosomal Dominant Polycystic Kidney Disease
    Authors:Vicente E. Torres, Mayo ClinicOlivier Devuyst, University of ZurichArlene Chapman, Emory UniversityRon T. Gansevoort, University of GroningenRonald D. Perrone, Tufts Medical CenterJohn Ouyang, Otsuka Pharmaceutical Development and CommercializationJaime D. Blais, Otsuka Pharmaceutical Development and CommercializationFrank S. Czerwiec, Otsuka Pharmaceutical Development and CommercializationOlga Sergeyeva, Otsuka Pharmaceutical Development and Commercialization
    Date:2017
    Publisher:Karger Publishers
    Publication Version:Author Accepted Manuscript (After Peer Review)